Christopher Gibson, Chief Executive Officer of Recursion Pharmaceuticals, recently sold a significant chunk of his company's common stock. The CEO of Recursion Pharmaceuticals recently disposed of 120 ...
Rani Therapeutics secured a $1.085 billion collaboration with Chugai Pharmaceutical. Check out why I am initiating with a Buy ...
The pharmaceutical company has also earned approval for Wegovy in treating metabolic dysfunction-associated steatohepatitis ...
CRMD, CELC, RANI, and RAPT are pushing aggressively to the upside on Monday. Here's what is driving these four biotech stocks ...
Rani Therapeutics stock surged 200% after securing a $1 billion partnership with Chugai and raising $60 million in funding.
Aurobindo Pharma stock analysis with support, resistance levels, F&O pointers, and trading strategy for potential profit.
Sunil Singhania, an ace investor and a Warren Buffett of India, just bought stakes in 4 less known stocks worth a total of ...
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 3.5% in the afternoon session after political comments ...
A fintech firm and two biotechs recently saw some huge insider buying. However, these were not the only insider purchases of ...
On the positive side of the ledger, Bayer is not short of catalysts: a reshaped pipeline covering both oncology and ...
Rubicon Research share price fell over 1% despite a strong market debut, opening at ₹620, up 27.83% from its issue price. The ...